Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Appropriations

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹6,351 Cr₹4,681 Cr₹3,382 Cr₹2,738 Cr₹2,680 Cr

What is the latest Appropriations of NATCO PHARMA ?

The latest Appropriations ratio of NATCO PHARMA is ₹6,351 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹6,351 Cr
Mar2024₹4,681 Cr
Mar2023₹3,382 Cr
Mar2022₹2,738 Cr
Mar2021₹2,680 Cr

How is Appropriations of NATCO PHARMA Trending?

Years Appropriations % Change
Mar2025 ₹6,351 Cr
35.69
Mar2024 ₹4,681 Cr
38.40
Mar2023 ₹3,382 Cr
23.51
Mar2022 ₹2,738 Cr
2.17
Mar2021 ₹2,680 Cr -

Compare Appropriations of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,954.2 Cr 0.9% 6.8% 0.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.9%

6.8%

0.6%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses